Vorinostat Completed Phase 3 Trials for Mesothelioma / Lung Cancers Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00128102 | Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1) |